Contribution of FPR and TLR9 to hypoxia-induced chemoresistance of ovarian cancer cells
Yongqing Cai,1 Jian Huang,2 Haiyan Xing,1 Bin Li,1 Ling Li,1 Xianfeng Wang,1 Dan Peng,1 Jianhong Chen1 1Department of Pharmacy, Daping Hospital and Research Institute of Surgery, Army Medical University, Chongqing 400042, China; 2Department of High Altitude Biology and Pathology, High Altitude Mili...
Main Authors: | Cai Y, Huang J, Xing H, Li B, Li L, Wang X, Peng D, Chen J |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2018-12-01
|
Series: | OncoTargets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/contribution-of-fpr-and-tlr9-to-hypoxia-induced-chemoresistance-of-ova-peer-reviewed-article-OTT |
Similar Items
-
Avaliação da Anexina A1, FPR1, FPR2 e miRNAs em adenocarcinoma gástrico
by: Stuchi, Nathália Maciel Maniezzo [UNESP]
Published: (2016) -
Formyl Peptide Receptor (FPR)1 Modulation by Resveratrol in an LPS-Induced Neuroinflammatory Animal Model
by: Rosa Calvello, et al.
Published: (2021-04-01) -
The Annexin A1 Receptor FPR2 Regulates the Endosomal Export of Influenza Virus
by: Fryad Rahman, et al.
Published: (2018-05-01) -
Research Progress of Preoperative FPR, FAR or AFR in Patients with Colorectal Cancer
by: Chen C, et al.
Published: (2021-02-01) -
FPR1 mediates the tumorigenicity of human cervical cancer cells
by: Cao G, et al.
Published: (2018-11-01)